Sanara MedTech Announces Board & Executive Compensation Changes
Ticker: SMTI · Form: 8-K · Filed: Oct 7, 2024 · CIK: 714256
| Field | Detail |
|---|---|
| Company | Sanara Medtech Inc. (SMTI) |
| Form Type | 8-K |
| Filed Date | Oct 7, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.001, $90,000, $5,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, executive-compensation, board-changes
TL;DR
Sanara MedTech shakes up board and exec pay - big governance news!
AI Summary
Sanara MedTech Inc. announced on October 4, 2024, a change in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key executives. This 8-K filing provides transparency on corporate governance and compensation adjustments within the company.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy, governance, or financial outlook, impacting investor confidence and stock performance.
Risk Assessment
Risk Level: medium — Changes in board and executive compensation can indicate internal shifts that may affect future performance or strategy.
Key Players & Entities
- Sanara MedTech Inc. (company) — Registrant
- Texas (location) — State of Incorporation
- October 4, 2024 (date) — Date of earliest event reported
FAQ
What specific changes were made to the board of directors?
The filing indicates the departure of certain directors and the election of new directors, though specific names are not detailed in the provided text.
Were there any changes to executive officer positions?
Yes, the filing mentions the departure of certain officers and updates to compensatory arrangements for certain officers.
What is the primary purpose of this 8-K filing?
The primary purpose is to report on the departure of directors or certain officers, the election of directors, and compensatory arrangements of certain officers, as well as Regulation FD disclosures and financial statements/exhibits.
When was the earliest event reported in this filing?
The earliest event reported was on October 4, 2024.
What is Sanara MedTech Inc.'s Standard Industrial Classification?
Sanara MedTech Inc.'s SIC code is 3842, related to Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Filing Stats: 1,013 words · 4 min read · ~3 pages · Grade level 9.6 · Accepted 2024-10-07 16:05:30
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value SMTI The Nasdaq Capital M
- $90,000 — yable in shares of restricted stock, of $90,000 per year for service on the Board and $
- $5,000 — 0 per year for service on the Board and $5,000 per year for service on the Corporate D
Filing Documents
- form8-k.htm (8-K) — 49KB
- ex99-1.htm (EX-99.1) — 14KB
- 0001493152-24-040275.txt ( ) — 242KB
- smti-20241004.xsd (EX-101.SCH) — 3KB
- smti-20241004_lab.xml (EX-101.LAB) — 33KB
- smti-20241004_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 7, 2024 Sanara MedTech Inc . By: /s/ Michael D. McNeil Name: Michael D. McNeil Title: Chief Financial Officer